Movalis (Meloxicam)

Meloxicam, the active ingredient in Movalis, is a Nonsteroidal anti-inflammatory drug (NSAID) presented as an injectable solution for intramuscular use. It is used to relieve pain and inflammation associated with osteoarthritis, rheumatoid arthritis, acute musculoskeletal pain, and post‑operative pain in adult patients.

GNH USA supplies Movalis as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality and regulatory compliance.

Movalis (meloxicam) is an NSAID that reduces inflammation and pain in musculoskeletal conditions.

- Osteoarthritis: reduces joint pain and improves functional ability. - Rheumatoid arthritis: alleviates inflammatory joint pain and swelling. - Acute musculoskeletal pain: provides rapid relief of pain and inflammation. - Post‑operative pain: helps control pain after surgical procedures.

Common Side Effects: - Gastrointestinal discomfort: nausea, dyspepsia, or abdominal pain. - Headache: mild to moderate intensity. - Dizziness or vertigo. - Injection site reactions: pain, erythema, or swelling. - Mild skin rash.

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding. - Cardiovascular thrombotic events such as myocardial infarction or stroke. - Severe skin reactions including Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Anaphylaxis or severe allergic reactions. - Hepatic injury: elevated liver enzymes or hepatitis.

Precautions should be taken when prescribing Movalis, especially in patients with existing health concerns.

- Assess renal function: monitor kidney function in patients with renal impairment. - Evaluate cardiovascular risk: use cautiously in patients with a history of heart disease. - Avoid in known hypersensitivity: do not use if allergic to meloxicam or other NSAIDs. - Use with caution in pregnancy: limited data, avoid in the third trimester. - Monitor liver enzymes: periodic testing recommended during prolonged therapy. - Store at ambient temperature: keep in the original pack, protect from moisture and light.

Meloxicam may interact with several drug classes; awareness of these interactions helps minimize risk.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of bleeding. - Other NSAIDs or COX‑2 inhibitors: heightened gastrointestinal and renal toxicity. - Selective serotonin reuptake inhibitors (SSRIs): elevated bleeding risk. - ACE inhibitors or diuretics: potential reduction in renal function.

Moderate Interactions (Monitor Closely): - Lithium: meloxicam may increase lithium serum levels. - Methotrexate: risk of increased toxicity. - Corticosteroids: combined use raises risk of gastrointestinal ulceration.